Related references
Note: Only part of the references are listed.Seasonal changes in epidermal ceramides are linked to impaired barrier function in acne patients
Apostolos Pappas et al.
EXPERIMENTAL DERMATOLOGY (2018)
Patterns of Ultraviolet Radiation Exposure and Skin Cancer Risk: the E3N-SunExp Study
Isabelle Savoye et al.
JOURNAL OF EPIDEMIOLOGY (2018)
Use of nicotinamide in dermatology
E. Forbat et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2017)
Efficacy and safety of nicotinamide in the management of hyperphosphatemia in pediatric patients on regular hemodialysis
Radwa El Borolossy et al.
PEDIATRIC NEPHROLOGY (2016)
Oral nicotinamide reduces transepidermal water loss: a randomized controlled trial
A. C. Chen et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients
A. C. Chen et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Nicotinamide and phosphate homeostasis in chronic kidney disease
Charles Ginsberg et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2016)
Clinical characteristics and epidermal barrier function of papulopustular rosacea: A comparison study with acne vulgaris
Maosong Zhou et al.
PAKISTAN JOURNAL OF MEDICAL SCIENCES (2016)
Is HPS2-THRIVE the death knell for niacin?
Peter P. Toth et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
Safety and tolerability of extended-release niacin-laropiprant: Pooled analyses for 11,310 patients in 12 controlled clinical trials
James McKenney et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention
Andrew C. Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?
Edward K. Geissler
TRANSPLANTATION RESEARCH (2015)
Nicotinamide and the skin
Andrew C. Chen et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2014)
Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in primary melanocytes
Benjamin C. Thompson et al.
EXPERIMENTAL DERMATOLOGY (2014)
Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
Martin J. Landray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A review of nicotinamide: treatment of skin diseases and potential side effects
Heidi M. Rolfe
JOURNAL OF COSMETIC DERMATOLOGY (2014)
Nicotinamide downregulates gene expression of interleukin-6, interleukin-10, monocyte chemoattractant protein-1, and tumour necrosis factor-α gene expression in HaCaT keratinocytes after ultraviolet B irradiation
G. Monfrecola et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2013)
Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients
Aurelie Lenglet et al.
DRUGS IN R&D (2013)
Nonmelanoma Skin Cancer in Solid Organ Transplant Recipients: Update on Epidemiology, Risk Factors, and Management
Gianpaolo Tessari et al.
DERMATOLOGIC SURGERY (2012)
Oral Nicotinamide Reduces Actinic Keratoses in Phase II Double-Blinded Randomized Controlled Trials
Devita Surjana et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Ultraviolet radiation and skin cancer
Deevya L. Narayanan et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2010)
Photoprotective effects of nicotinamide
Diona L. Damian
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2010)
Nicotinamide Prevents Ultraviolet Radiation-induced Cellular Energy Loss
Joohong Park et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2010)
Topical nicotinamide modulates cellular energy metabolism and provides broad-spectrum protection against ultraviolet radiation-induced immunosuppression in humans
G. Sivapirabu et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in humans
Eleni Yiasemides et al.
CARCINOGENESIS (2009)
Release of cytokines/chemokines and cell death in UVB-irradiated human keratinocytes, HaCaT
Masakazu Yoshizumi et al.
CELL BIOLOGY INTERNATIONAL (2008)
A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients
Steven C. Cheng et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide
Diona L. Damian et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Nicotinamide in dermatology: a capsule summary
Mohammad R. Namazi
INTERNATIONAL JOURNAL OF DERMATOLOGY (2007)
Safety considerations with niacin therapy
John R. Guyton et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis
David Martin-Oliva et al.
CANCER RESEARCH (2006)
Diarrhea induced by high doses of nicotinamide in dialysis patients
P Delanaye et al.
KIDNEY INTERNATIONAL (2006)
Thrombocytopenia induced by nicotinamide in hemodialysis patients
JB Rottembourg et al.
KIDNEY INTERNATIONAL (2005)
Low-dose Retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients - A 16-year retrospective study
CA Harwood et al.
ARCHIVES OF DERMATOLOGY (2005)
Moisturizing effects of topical nicotinamide on atopic dry skin
Y Soma et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2005)
Measurement of sunscreen immune protection factors in humans: A consensus paper
A Fourtanier et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
European Nicotinamide Diabetes Intervention Trial (ENDIT):: a randomised controlled trial of intervention before the onset of type 1 diabetes
EAM Gale et al.
LANCET (2004)
Nicotinamide suppresses hyperphosphatemia in hemodialysis patients
Y Takahashi et al.
KIDNEY INTERNATIONAL (2004)
Pellagra and skin
K Karthikeyan et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2002)
Safety of high dose nicotinamide: a review
M Knip et al.
DIABETOLOGIA (2000)
Share Paper
